Compounds of formula I and IV are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorder: ##STR00001## wherein the variables A-B, R.sup.1, R.sup.2, m, and Q are described herein.

 
Web www.patentalert.com

< Pyrrolopyridine derivatives and their use as Crth2 antagonists

> Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

> Aminoindazole derivatives as medicaments and pharmaceutical compositions including them

~ 00582